Finance

Lists
ENTX:NASDAQ
Entera Bio Ltd
US$ ३.१०
+१.३१%
(+०.०४०) 1D
US$ ३.०७
-०.९७% (-०.०३०)
After hours
Closed: अक्टोबर २८, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTX...
Open
US$ ३.०५
High
US$ ३.२०
Low
US$ ३.००
Mkt. cap
५३.९२ करोड
Avg. vol.
६.०७ लाख
Volume
१.८२ लाख
52-wk high
US$ ४.२०
52-wk low
US$ ०.९१
EPS
-US$ ०.३५
Beta
१.४०
Shares outstanding
१७.३९ करोड
No. of employees
२१
Open
US$ ३.०५
High
US$ ३.२०
Low
US$ ३.००
Mkt. cap
५३.९२ करोड
Avg. vol.
६.०७ लाख
Volume
१.८२ लाख
52-wk high
US$ ४.२०
52-wk low
US$ ०.९१
EPS
-US$ ०.३५
Beta
१.४०
Shares outstanding
१७.३९ करोड
No. of employees
२१
News stories
From web sources and news partners
Investing.com Canada
Investing.com Canada
·
१ दिन पहिले
Form 8K Entera Bio Ltd. For: 27 October By Investing.com
Investing.com India
Investing.com India
·
१ दिन पहिले
Entera Bio appoints Juan Arjona Ferreira to board of directors By Investing.com
About Entera Bio Ltd
CEO-
Employees२१
Founded२००९
Headquarters-
Sector-
Websiteenterabio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ENTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENTX in the last 3 months.
Highest
Current US$ ३.१०
US$ ११.०० (+२५४.८४%)
Average
US$ १०.०० (+२२२.५८%)
Lowest
US$ ९.०० (+१९०.३२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Initiated
US$ ११.००
+२५४.८%
09/24/2026
Patrick Dolezal
LifeSci Capital
Buy
Initiated
US$ १०.००
+२२२.६%
09/23/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
09/22/2026
David Risinger
Leerink Partners
Buy
Initiated
US$ ९.००
+१९०.३%
09/18/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ९.००
+१९०.३%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१६.४३ लाख
१७.१८ लाख
२२.५१ लाख
३२.०१ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१६.१३ लाख
१३.२४ लाख
१२.८८ लाख
१३.६२ लाख
Operating expense
३२.५६ लाख
३०.४२ लाख
३५.३९ लाख
४५.६३ लाख
Total operating expenses
३२.५६ लाख
३०.४२ लाख
३५.३९ लाख
४५.६३ लाख
Operating income
-३२.५६ लाख
-३०.४२ लाख
-३५.३९ लाख
-४५.६३ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-३२.०० लाख
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
EBT excluding unusual items
-३२.०० लाख
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३२.०० लाख
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
५६.०० हजार
२६.०० हजार
३४.०० हजार
-
Interest expense
-
-
-
-२७.४९ लाख
Net interest expenses
५६.०० हजार
२६.०० हजार
३४.०० हजार
-२७.४९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३२.४८ लाख
-३०.३५ लाख
-३५.३२ लाख
-४५.५४ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू